Steve Averbuch

Steven D. Averbuch, M.D. is a medical oncologist and pharmaceutical industry veteran with more than 35 years in oncology drug development and more than a decade in biomarker and drug diagnostic co-development. He has contributed to multiple drug and companion diagnostic approvals in the U.S. and other major markets.

Prior to joining industry, Dr. Averbuch held academic appointments at the Mount Sinai School of Medicine and the U.S. Public Health Service (USPHS) School of Medicine. He received his M.D. and Internal Medicine training from the University of Illinois, Chicago and his Medical Oncology training at the National Cancer Institute in Bethesda, Maryland.